StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

BioCorRx's free cash flow for the twelve months ending Dec 31, 2019 was -$2.81M. For fiscal 2022 it was -$2.04M. The highest annual figure on record is $167.18K in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$2.04M–
FY2021Dec 31, 2021-$3.54M–
FY2020Dec 31, 2020-$2.15M–
FY2019Dec 31, 2019-$2.81M–
FY2018Dec 31, 2018-$1.79M–
FY2017Dec 31, 2017-$2.54M–
FY2016Dec 31, 2016-$2.31M-1478.8%
FY2014Dec 31, 2014$167.18K+72.7%
FY2013Dec 31, 2013$96.79K–
FY2012Dec 31, 2012-$928.58K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019-$834.19K–
Q3 FY2019Sep 30, 2019-$688.27K–
Q2 FY2019Jun 30, 2019-$1.01M–
Q1 FY2019Mar 31, 2019-$285.16K–
Q4 FY2018Dec 31, 2018-$438.43K–
Q3 FY2018Sep 30, 2018-$372.11K–
Q4 FY2016Dec 31, 2016-$505.80K–
Q3 FY2016Sep 30, 2016-$732.81K–
Q2 FY2016Jun 30, 2016-$734.73K–
Q1 FY2016Mar 31, 2016-$331.71K–

More BioCorRx figures

See a number that looks wrong?